Search - tctmd.com

Displaying 181 - 200 of 406

Sort: Relevancy | Date

Presentation THT 2026

Barostimulation Therapy for HFrEF

Presenter: Philip Adamson, MD

March 03, 2026

Presentation THT 2026

Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial

Presenter: Sanjiv J. Shah

March 03, 2026

Presentation THT 2026

Defining the Targets for Gene Therapy and Optimizing Vectors for Delivery

Presenter: Roger J. Hajjar

March 03, 2026

Presentation THT 2026

Medication Regimen Changes and Clinical Outcomes in the Cardiac Microcurrent (C-MIC) II Randomized Trial

Presenter: Marat Fudim

March 03, 2026

Presentation THT 2026

The Lymphatic System as a Target for ADHF

Presenter: Jan Biegus

March 03, 2026

Presentation THT 2026

Artificial Intelligence Meets Real-World Heart Failure: Early Results from the HF-TRACK Trial

Presenter: Shamus Husheer

March 03, 2026

Presentation THT 2026

Reducing Renal Venous Pressure to Improve Urine Output: Overview of Devices, Current Status, and Future Directions

Presenter: Arvind Bhimaraj

March 03, 2026

Presentation THT 2026

Incidence of HF Therapy Escalation and Time-to-Clinical Worsening in Atrial Shunt- vs. Sham-Treated Patients with HFpEF/HFmrEF During 5-Year Follow-Up: REDUCE LAP-HF II Trial

Presenter: Grant Reed

March 03, 2026

Presentation THT 2026

Advanced Hemodynamics To Guide Recovery, Prognosis, and Clinical Care

Presenter: Michele Esposito

March 03, 2026

Presentation THT 2026

Sex- and Race‑Based Differences in Outcomes Following Left Ventricular Assist Device Explant: A VAD Wean Registry Analysis

Presenter: Toluwalase Awoyemi

March 03, 2026

Presentation THT 2026

Pumps that Increase Renal Arterial Perfusion Pressure: Current Status and Future Directions

Presenter: Robby Wu

March 03, 2026

Presentation THT 2026

Optimal Mean Arterial Pressure, Time in Target Range, and Outcomes in HeartMate 3 Recipients: Pooled Individual-Patient Data from MOMENTUM-3 and ARIES-HM3 Trials

Presenter: Nelson Wang

March 03, 2026

Presentation THT 2026

Impact of Revascularization Strategy on Native Heart Survival in Patients with Cardiogenic Shock Supported by Full LV Unloading

Presenter: Frailyn J. Nunez

March 03, 2026

Presentation THT 2026

The Role of Provocative Hemodynamic Testing in Clinical Practice

Presenter: Susanna S. Mak

March 03, 2026

Presentation THT 2026

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Presenter: Benjamin Hibbert

March 03, 2026

Presentation THT 2026

Renal Replacement Therapies: Overview of Systems and When to Use Each

Presenter: Wendy McCallum

March 03, 2026

Presentation THT 2026

Complete Hemodynamic Profiling of a Full Support Microaxial Flow Pump: Systemic, Microvascular, and Ventricular Unloading

Presenter: James W. Schurr

March 03, 2026

Presentation THT 2026

Microaxial Flow Pump Use in Different Phenotypes of Cardiogenic Shock – a Secondary Analysis of the DanGer Shock Trial

Presenter: Elric Zweck

March 03, 2026

Presentation THT 2026

Bringing PV Loops to the Bedside

Presenter: Mohammed Imran Aslam

March 03, 2026

Presentation THT 2026

Noninvasive Fluid Removal for ADHF: Turning Eccrine Glands Into Nephrons

Presenter: Daniel R. Bensimhon

March 03, 2026

Advertisement

Barostimulation Therapy for HFrEF

Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial

Defining the Targets for Gene Therapy and Optimizing Vectors for Delivery

Medication Regimen Changes and Clinical Outcomes in the Cardiac Microcurrent (C-MIC) II Randomized Trial

The Lymphatic System as a Target for ADHF

Artificial Intelligence Meets Real-World Heart Failure: Early Results from the HF-TRACK Trial

Reducing Renal Venous Pressure to Improve Urine Output: Overview of Devices, Current Status, and Future Directions

Incidence of HF Therapy Escalation and Time-to-Clinical Worsening in Atrial Shunt- vs. Sham-Treated Patients with HFpEF/HFmrEF During 5-Year Follow-Up: REDUCE LAP-HF II Trial

Advanced Hemodynamics To Guide Recovery, Prognosis, and Clinical Care

Sex- and Race‑Based Differences in Outcomes Following Left Ventricular Assist Device Explant: A VAD Wean Registry Analysis

Pumps that Increase Renal Arterial Perfusion Pressure: Current Status and Future Directions

Optimal Mean Arterial Pressure, Time in Target Range, and Outcomes in HeartMate 3 Recipients: Pooled Individual-Patient Data from MOMENTUM-3 and ARIES-HM3 Trials

Impact of Revascularization Strategy on Native Heart Survival in Patients with Cardiogenic Shock Supported by Full LV Unloading

The Role of Provocative Hemodynamic Testing in Clinical Practice

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Renal Replacement Therapies: Overview of Systems and When to Use Each

Complete Hemodynamic Profiling of a Full Support Microaxial Flow Pump: Systemic, Microvascular, and Ventricular Unloading

Microaxial Flow Pump Use in Different Phenotypes of Cardiogenic Shock – a Secondary Analysis of the DanGer Shock Trial

Bringing PV Loops to the Bedside

Noninvasive Fluid Removal for ADHF: Turning Eccrine Glands Into Nephrons

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content